Metastasizing pleomorphic adenoma presenting as an asymptomatic kidney tumor twenty-nine years after parotidectomy – urological viewpoint and overview of the literature to date
Pleomorphic adenomas (benign mixed tumors) are the most common tumors of glandular origin in the head and neck and are one of the few benign neoplasms that can undergo malignant transformation. 1 Mixed tumors that are seemingly benign at the microscopic level but metastasize have been termed metasta...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2009-12-01
|
Series: | Rare Tumors |
Online Access: | https://doi.org/10.4081/rt.2009.e54 |
id |
doaj-c247a96c18d8450897cca9af3cb37bf4 |
---|---|
record_format |
Article |
spelling |
doaj-c247a96c18d8450897cca9af3cb37bf42020-11-25T03:35:51ZengSAGE PublishingRare Tumors2036-36132009-12-01110.4081/rt.2009.e54Metastasizing pleomorphic adenoma presenting as an asymptomatic kidney tumor twenty-nine years after parotidectomy – urological viewpoint and overview of the literature to dateJan Ebbing0Carolin Blind1Harald Stein2Kurt Miller3Christoph Loddenkemper4Department of Urology, and Charité–Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, GermanyInstitute of Pathology, Charité–Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, GermanyInstitute of Pathology, Charité–Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, GermanyDepartment of Urology, and Charité–Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, GermanyInstitute of Pathology, Charité–Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, GermanyPleomorphic adenomas (benign mixed tumors) are the most common tumors of glandular origin in the head and neck and are one of the few benign neoplasms that can undergo malignant transformation. 1 Mixed tumors that are seemingly benign at the microscopic level but metastasize have been termed metastasizing mixed tumors (MZMTs). The entity of metastasizing benign mixed tumors has been reported since the early 1940s, with up to approximately 50 cases described in the literature to date. Despite their bland morphologic appearance, MZMTs have been associated with an overall mortality rate of about 20–40%. We report the case of a MZMT of the kidney almost 30 years after lateral parotidectomy owing to the same tumor entity. For benign mixed tumors, we are unaware of more than two other cases of metastasis to the kidney that have been published, whereas metastases to the bone, lung, and lymph nodes are more common. Parotidectomy is widely accepted as the first choice of treatment, 13 but once metastases have occurred the therapeutic strategy is uncertain with surgery being the only curative option in cases with resectable disease. This case report provides information about the rare event of metastatic disease to the kidney and points out therapeutic strategies. However, in view of the general lack of adequate information in the literature, the best therapy for systemic disease still remains unresolved.https://doi.org/10.4081/rt.2009.e54 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jan Ebbing Carolin Blind Harald Stein Kurt Miller Christoph Loddenkemper |
spellingShingle |
Jan Ebbing Carolin Blind Harald Stein Kurt Miller Christoph Loddenkemper Metastasizing pleomorphic adenoma presenting as an asymptomatic kidney tumor twenty-nine years after parotidectomy – urological viewpoint and overview of the literature to date Rare Tumors |
author_facet |
Jan Ebbing Carolin Blind Harald Stein Kurt Miller Christoph Loddenkemper |
author_sort |
Jan Ebbing |
title |
Metastasizing pleomorphic adenoma presenting as an asymptomatic kidney tumor twenty-nine years after parotidectomy – urological viewpoint and overview of the literature to date |
title_short |
Metastasizing pleomorphic adenoma presenting as an asymptomatic kidney tumor twenty-nine years after parotidectomy – urological viewpoint and overview of the literature to date |
title_full |
Metastasizing pleomorphic adenoma presenting as an asymptomatic kidney tumor twenty-nine years after parotidectomy – urological viewpoint and overview of the literature to date |
title_fullStr |
Metastasizing pleomorphic adenoma presenting as an asymptomatic kidney tumor twenty-nine years after parotidectomy – urological viewpoint and overview of the literature to date |
title_full_unstemmed |
Metastasizing pleomorphic adenoma presenting as an asymptomatic kidney tumor twenty-nine years after parotidectomy – urological viewpoint and overview of the literature to date |
title_sort |
metastasizing pleomorphic adenoma presenting as an asymptomatic kidney tumor twenty-nine years after parotidectomy – urological viewpoint and overview of the literature to date |
publisher |
SAGE Publishing |
series |
Rare Tumors |
issn |
2036-3613 |
publishDate |
2009-12-01 |
description |
Pleomorphic adenomas (benign mixed tumors) are the most common tumors of glandular origin in the head and neck and are one of the few benign neoplasms that can undergo malignant transformation. 1 Mixed tumors that are seemingly benign at the microscopic level but metastasize have been termed metastasizing mixed tumors (MZMTs). The entity of metastasizing benign mixed tumors has been reported since the early 1940s, with up to approximately 50 cases described in the literature to date. Despite their bland morphologic appearance, MZMTs have been associated with an overall mortality rate of about 20–40%. We report the case of a MZMT of the kidney almost 30 years after lateral parotidectomy owing to the same tumor entity. For benign mixed tumors, we are unaware of more than two other cases of metastasis to the kidney that have been published, whereas metastases to the bone, lung, and lymph nodes are more common. Parotidectomy is widely accepted as the first choice of treatment, 13 but once metastases have occurred the therapeutic strategy is uncertain with surgery being the only curative option in cases with resectable disease. This case report provides information about the rare event of metastatic disease to the kidney and points out therapeutic strategies. However, in view of the general lack of adequate information in the literature, the best therapy for systemic disease still remains unresolved. |
url |
https://doi.org/10.4081/rt.2009.e54 |
work_keys_str_mv |
AT janebbing metastasizingpleomorphicadenomapresentingasanasymptomatickidneytumortwentynineyearsafterparotidectomyurologicalviewpointandoverviewoftheliteraturetodate AT carolinblind metastasizingpleomorphicadenomapresentingasanasymptomatickidneytumortwentynineyearsafterparotidectomyurologicalviewpointandoverviewoftheliteraturetodate AT haraldstein metastasizingpleomorphicadenomapresentingasanasymptomatickidneytumortwentynineyearsafterparotidectomyurologicalviewpointandoverviewoftheliteraturetodate AT kurtmiller metastasizingpleomorphicadenomapresentingasanasymptomatickidneytumortwentynineyearsafterparotidectomyurologicalviewpointandoverviewoftheliteraturetodate AT christophloddenkemper metastasizingpleomorphicadenomapresentingasanasymptomatickidneytumortwentynineyearsafterparotidectomyurologicalviewpointandoverviewoftheliteraturetodate |
_version_ |
1724552682662789120 |